Quick Answer
Satellos Bioscience Inc. reported total equity of $27.78 million for fiscal year 2025 (IFRS, Form 20-F).
Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted.
Satellos Bioscience Inc. Total Equity — Annual History
| Fiscal Year | Total Equity | YoY Change |
|---|---|---|
| 2025 | $27.78M | -41.1% |
| 2024 | $47.16M | +53.3% |
| 2023 | $30.76M | — |
- Satellos Bioscience Inc.’s total equity fell 41.1% year over year.
- The most recent figure is from Satellos Bioscience Inc.’s fiscal year 2025 annual report (Form 20-F), filed March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 19, 2026.
Last verified: